CRX08: Who's who of clinical research
06 August, 2008 by Fiona WylieFresh from his role as one of the head spruikers of Queensland biotech at BIO in San Diego and DIA in Boston, the CEO of the Queensland Clinical Trials Network, Mario Pennisi, is looking forward to hosting CRX08.
Bone union for Mesoblast
06 August, 2008 by Dylan Bushell-EmblingPatients achieve bone union in long-time non-healing bones after implantation of Mesoblast's adult stem cells
Ciba turns down Biosignal compounds
06 August, 2008 by Dylan Bushell-EmblingBad news for Biosignal on Ciba evaluation agreement
ResMed reports stellar result
06 August, 2008 by Dylan Bushell-EmblingResMed's share price soars following impressive fourth-quarter and financial year earnings figures.
HeartWare to go OS
05 August, 2008 by Dylan Bushell-EmblingHeartWare to transfer corporate responsibility to US
Streamline for QRxPharma
05 August, 2008 by Dylan Bushell-EmblingFDA approves QRxPharma's streamlined testing protocol
Minomic says no to Probiomics
31 July, 2008 by Kate McDonaldMinomic has withdrawn from a proposed merger with Probiomics
Hexima puts up its defensins
31 July, 2008 by Dylan Bushell-EmblingHexima releases details of field trials against common crop fungal pathogens
Portland denies patent infringement
31 July, 2008 by Dylan Bushell-EmblingSydney prosthetics companies in hip cup barney
OMI heads north again
31 July, 2008 by Dylan Bushell-EmblingOMI finds Canadian distribution partner for safety syringes
Biota completes new flu trial
31 July, 2008 by Dylan Bushell-EmblingPhase II trials of long-acting compound conclude, Phase III next
Innovation review extended
31 July, 2008 by Kate McDonaldDeadline for Innovation Review green paper extended by a month
ASCC board sacks Livesey
31 July, 2008 by Kate McDonaldStephen Livesey has "departed" the ASCC over difference with board
AtCor's pressure rises
30 July, 2008 by Dylan Bushell-EmblingExcellent sales results reported by AtCor
Lancet for Prana
30 July, 2008 by Dylan Bushell-EmblingLancet Neurology publishes Prana's PBT2 trial results
